MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.xcrm.2025.102292

Медицинская библиотека · Cell reports. Medicine · 2025

A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma.

Li Jiaqi, Ma Chaozhe, Cao Pei, Guo Weihua, Wang Pengyu, Yang Yang, Ding Bowen, Yin Fengyi, Li Zhe, Wang Yifei, Li Shouyi, Huang Chongbiao, Wang Xiuchao, Zhou Tianxing, Chang Antao, Zhao Liang, Gao Song, Zhao Tiansuo, Wang Hongwei, Yu Jun, Xu Jingyuan, Feng Yukuan, Hao Jihui

СтатьяПеревод пока не подготовлен

Аннотация

CD147 has emerged as a promising tumor-specific therapeutic target. Identifying small-molecule inhibitors that promote its proteolysis represents a critical step toward advancing clinical translation, while elucidating its mechanisms of action could further accelerate this process. In this study, we identify dracorhodin perchlorate (DP) as a potent CD147 inhibitor that induces autophagy-dependent degradation. DP significantly inhibits cell proliferation and enhances sensitivity to gemcitabine in pancreatic cancer cells. Mechanistically, CD147 inhibition upregulates acyl-CoA synthetase long-chain family member 4 (ACSL4) expression through H3K9 lactylation and suppresses the sterol regulatory element-binding protein 1 (SREBP1)/stearoyl-CoA desaturase-1 (SCD1) signaling pathway, collectively disrupting the balance of polyunsaturated and monounsaturated fatty acids, ultimately triggering ferroptosis. The combination of DP and gemcitabine demonstrates remarkable synergistic anti-tumor effects in orthotopic xenograft models, spontaneous KPC mouse models, and patient-derived organoid (PDO) and xenograft (PDX) models. In conclusion, this study reveals a mechanism by which CD147 regulates ferroptosis and supports combining DP with gemcitabine as a therapeutic strategy to improve patient outcomes in pancreatic ductal adenocarcinoma.

Для цитирования: Li Jiaqi, Ma Chaozhe, Cao Pei, Guo Weihua, Wang Pengyu, Yang Yang, Ding Bowen, Yin Fengyi, Li Zhe, Wang Yifei, Li Shouyi, Huang Chongbiao, Wang Xiuchao, Zhou Tianxing, Chang Antao, Zhao Liang, Gao Song, Zhao Tiansuo, Wang Hongwei, Yu Jun, Xu Jingyuan, Feng Yukuan, Hao Jihui. A CD147-targeted small-molecule inhibitor potentiates gemcitabine efficacy by triggering ferroptosis in pancreatic ductal adenocarcinoma.. Cell reports. Medicine. 2025. DOI: 10.1016/j.xcrm.2025.102292.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.